The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants

被引:98
作者
Muennig, P
Pallin, D
Sell, RL
Chan, MS
机构
[1] New York City Dept Hlth, Refugee Hlth Program, New York, NY 10013 USA
[2] New York City Dept Hlth, Prevent Med Residency Program, New York, NY 10013 USA
[3] Columbia Univ, Sch Publ Hlth, Div Sociomed Sci, New York, NY USA
[4] Univ Oxford, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford, England
关键词
D O I
10.1056/NEJM199903113401006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Currently, more than 600,000 immigrants enter the United States each year from countries where intestinal parasites are endemic. At entry persons with parasitic infections may be asymptomatic, and stool examinations are not a sensitive method of screening for parasitosis. Albendazole is a new, broad-spectrum antiparasitic drug, which was approved recently by the Food and Drug Administration. International trials have shown albendazole to be safe and effective in eradicating many parasites. In the United States there is now disagreement about whether to screen all immigrants for parasites, treat all immigrants presumptively, or do nothing unless they have symptoms. Methods We compared the costs and benefits of no preventive intervention (watchful waiting) with those of universal screening or presumptive treatment with 400 mg of albendazole per day for five days. Those at risk were defined as immigrants to the United States from Asia, the Middle East, sub-Saharan Africa, Eastern Europe, and Latin America and the Caribbean. Cost effectiveness was expressed both in terms of the cost of treatment per disability-adjusted life-year (DALY) averted (one DALY is defined as the loss of one year of healthy life to disease) and in terms of the cost per hospitalization averted. Results As compared with watchful waiting, presumptive treatment of all immigrants at risk for parasitosis would avert at least 870 DALYs, prevent at least 33 deaths and 374 hospitalizations, and save at least $4.2 million per year. As compared with watchful waiting, screening would cost $159,236 per DALY averted. Conclusions Presumptive administration of albendazole to all immigrants at risk for parasitosis would save lives and money. Universal screening, with treatment of persons with positive stool examinations, would save lives but is less cost effective than presumptive treatment. (N Engl J Med 1999;340:773-9.) (C)1999, Massachusetts Medical Society.
引用
收藏
页码:773 / 779
页数:7
相关论文
共 48 条
[1]  
*AG HLTH CAR POL R, 1994, HCUP3 AG HLTH CAR PO
[2]   A RANDOMIZED CONTROLLED TRIAL COMPARING MEBENDAZOLE AND ALBENDAZOLE AGAINST ASCARIS, TRICHURIS AND HOOKWORM INFECTIONS [J].
ALBONICO, M ;
SMITH, PG ;
HALL, A ;
CHWAYA, HM ;
ALAWI, KS ;
SAVIOLI, L .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1994, 88 (05) :585-589
[3]   Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs [J].
Allan, JC ;
VelasquezTohom, M ;
Fletes, C ;
TorresAlvarez, R ;
LopezVirula, G ;
Yurrita, P ;
deAlfaro, HS ;
Rivera, A ;
GarciaNoval, J .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1997, 91 (05) :595-598
[4]  
ANDERSON JP, 1985, JAMA-J AM MED ASSOC, V15, P2229
[5]  
ARCHIBALD LK, 1993, Q J MED, V86, P191
[6]  
ARFAA F, 1981, J FAM PRACTICE, V12, P223
[7]   DIRECT DOLLAR COSTS AND SAVINGS OF SCREENING STOOL EXAMINATIONS FOR EGGS AND PARASITES IN ADULT SOUTHEAST ASIAN REFUGEES [J].
BARRETTCONNOR, E .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1982, 31 (03) :466-468
[8]   PREVALENCE OF INTESTINAL PARASITES AND ASSOCIATION WITH SYMPTOMS IN SOUTHEAST-ASIAN REFUGEES [J].
BUCHWALD, D ;
LAM, M ;
HOOTON, TM .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1995, 20 (05) :271-275
[9]   HEALTH-STATUS OF REFUGEES FROM VIETNAM, LAOS, AND CAMBODIA [J].
CATANZARO, A ;
MOSER, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (09) :1303-1308
[10]   Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation [J].
Cromwell, J ;
Bartosch, WJ ;
Fiore, MC ;
Hasselblad, V ;
Baker, T .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (21) :1759-1766